FXR regulates organic solute transporters alpha and beta in the adrenal gland, kidney, and intestine.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Lipid Research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 16251721
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• OSTalpha-OSTbeta: a major basolateral bile acid and steroid transporter in human intestinal, renal, and biliary epithelia.

  2005cited by this paper
• Activation of the nuclear receptor FXR induces fibrinogen expression: a new role for bile acid signaling Published, JLR Papers in Press, December 16, 2004. DOI 10.1194/jlr.M400292-JLR200

  2005cited by this paper
• α-Crystallin Is a Target Gene of the Farnesoid X-activated Receptor in Human Livers*

  2005cited by this paper
• Regulation of Complement C3 Expression by the Bile Acid Receptor FXR*

  2005influential reference
• The heteromeric organic solute transporter alpha-beta, Ostalpha-Ostbeta, is an ileal basolateral bile acid transporter.

  2005influential reference
• Peroxisome proliferator-activated receptor-gamma coactivator 1alpha (PGC-1alpha) regulates triglyceride metabolism by activation of the nuclear receptor FXR.

  2004cited by this paper
• Targeted Deletion of the Ileal Bile Acid Transporter Eliminates Enterohepatic Cycling of Bile Acids in Mice*

  2003cited by this paper
• Functional Complementation between a Novel Mammalian Polygenic Transport Complex and an Evolutionarily Ancient Organic Solute Transporter, OSTα-OSTβ*

  2003cited by this paper
• Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis.

  2003cited by this paper
• Syndecan-1 Expression Is Regulated in an Isoform-specific Manner by the Farnesoid-X Receptor*

  2003cited by this paper
• Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis.

  2003cited by this paper
• Natural Structural Variants of the Nuclear Receptor Farnesoid X Receptor Affect Transcriptional Activation*

  2003cited by this paper
• Farnesoid X receptor and bile salts are involved in transcriptional regulation of the gene encoding the human bile salt export pump

  2002influential reference
• Identification of PLTP as an LXR target gene and apoE as an FXR target gene reveals overlapping targets for the two nuclear receptors Published, JLR Papers in Press, October 16, 2002. DOI 10.1194/jlr.C200014-JLR200

  2002cited by this paper
• Bile acids regulate the ontogenic expression of ileal bile acid binding protein in the rat via the farnesoid X receptor.

  2002cited by this paper
• BAREing it all: the adoption of LXR and FXR and their roles in lipid homeostasis.

  2002cited by this paper
• Generation of multiple farnesoid-X-receptor isoforms through the use of alternative promoters.

  2002influential reference
• Regulation of the ileal bile acid-binding protein gene: An approach to determine its physiological function(s)

  2002cited by this paper
• Regulation of Multidrug Resistance-associated Protein 2 (ABCC2) by the Nuclear Receptors Pregnane X Receptor, Farnesoid X-activated Receptor, and Constitutive Androstane Receptor*

  2002cited by this paper
• Disrupted Bile Acid Homeostasis Reveals an Unexpected Interaction among Nuclear Hormone Receptors, Transporters, and Cytochrome P450*

  2001cited by this paper
• Human Bile Salt Export Pump Promoter Is Transactivated by the Farnesoid X Receptor/Bile Acid Receptor*

  2001influential reference
• Transport of bile acids in hepatic and non-hepatic tissues.

  2001cited by this paper
• Farnesoid X-activated receptor induces apolipoprotein C-II transcription: a molecular mechanism linking plasma triglyceride levels to bile acids.

  2001cited by this paper
• Expression cloning of two genes that together mediate organic solute and steroid transport in the liver of a marine vertebrate

  2001cited by this paper
• Catabolites of cholesterol synthesis pathways and forskolin as activators of the farnesoid X-activated nuclear receptor.

  2000cited by this paper
• A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis.

  2000cited by this paper
• Identification of the DNA Binding Specificity and Potential Target Genes for the Farnesoid X-activated Receptor*

  2000cited by this paper
• Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis.

  2000cited by this paper
• The Farnesoid X-activated Receptor Mediates Bile Acid Activation of Phospholipid Transfer Protein Gene Expression*

  2000influential reference
• Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors.

  2000cited by this paper
• Endogenous bile acids are ligands for the nuclear receptor FXR/BAR.

  1999cited by this paper
• Identification of a Bile Acid-responsive Element in the Human Ileal Bile Acid-binding Protein Gene

  1999influential reference
• Bile acids: natural ligands for an orphan nuclear receptor.

  1999cited by this paper
• Identification of a nuclear receptor for bile acids.

  1999cited by this paper
• The RXR heterodimers and orphan receptors.

  1995cited by this paper
• Identification of a nuclear receptor that is activated by farnesol metabolites.

  1995influential reference
• Isolation of proteins that interact specifically with the retinoid X receptor: two novel orphan receptors.

  1995cited by this paper
• The nuclear receptor superfamily: the second decade.

  1995cited by this paper
• Differential recognition of target genes by nuclear receptor monomers, dimers, and heterodimers.

  1994cited by this paper
• The NCI-H295 cell line: a pluripotent model for human adrenocortical studies.

  1994cited by this paper
• Expression and localization of intestinal 15 kDa protein in the rat

  1993cited by this paper
• Immunocytochemical localization of rat intestinal 15 kDa protein, a member of cytoplasmic fatty acid‐binding proteins

  1992cited by this paper
• Taurocholate transport by rat intestinal basolateral membrane vesicles. Evidence for the presence of an anion exchange transport system.

  1986cited by this paper
• Intrahepatic cholestasis induced by drugs and chemicals.

  1976cited by this paper

• Hepatic and intestinal tissue-specific Fxr deficiency alters bile acid homeostasis in female mice.

  2025cites this paper
• Bile acid signaling in MASLD: from pathogenesis to therapeutic applications.

  2025cites this paper
• Porcine bile acids improve performance by altering hepatic lipid metabolism and amino acid metabolism with different protein level diets in late laying hens

  2025cites this paper
• Structural Basis of Novel Bile Acid-Based Modulators of FXR.

  2025cites this paper
• FXR-FGF19 signaling in the gut–liver axis is dysregulated in patients with cirrhosis and correlates with impaired intestinal defence

  2024cites this paper
• Retinoid X receptor heterodimers in hepatic function: structural insights and therapeutic potential

  2024cites this paper
• Farnesoid X receptor (FXR) as a potential therapeutic target for lung diseases: a narrative review

  2024cites this paper
• Bile Acid Signaling in Metabolic and Inflammatory Diseases and Drug Development

  2024cites this paper
• Investigational farnesoid X receptor agonists for the treatment of primary biliary cholangitis

  2024cites this paper
• Bile Acids and Farnesoid X Receptor in Renal Pathophysiology

  2024cites this paper
• Farnesoid X receptor agonist tropifexor detoxifies ammonia by regulating the glutamine metabolism and urea cycles in cholestatic livers.

  2024cites this paper
• Bile acid and nonalcoholic steatohepatitis: Molecular insights and therapeutic targets

  2023cites this paper
• FXR agonists for colorectal and liver cancers, as a stand-alone or in combination therapy.

  2023cites this paper
• Bile Acids Alter the Autophagy and Mitogenesis in Skeletal Muscle Cells.

  2023cites this paper
• Steroid hormone signaling: What we can learn from insect models.

  2023cites this paper
• Exhaustively Exploring the Prevalent Interaction Pathways of Ligands Targeting the Ligand-Binding Pocket of Farnesoid X Receptor via Combined Enhanced Sampling

  2023cites this paper
• The regulation of tissue-specific farnesoid X receptor on genes and diseases involved in bile acid homeostasis.

  2023cites this paper
• Bile acid metabolism involved into the therapeutic action of Xiaojianzhong Tang via gut microbiota to treat chronic atrophic gastritis in rats.

  2022cites this paper
• Pleiotropic roles of FXR in liver and colorectal cancers.

  2022cites this paper
• Enterohepatic and non-canonical roles of farnesoid X receptor in controlling lipid and glucose metabolism.

  2022cites this paper
• Alisol B 23-acetate adjusts bile acid metabolisim via hepatic FXR-BSEP signaling activation to alleviate atherosclerosis.

  2022cites this paper
• Advances in understanding the regulatory mechanism of organic solute transporter α-β.

  2022cites this paper
• Intratracheal exposure to polyhexamethylene guanidine phosphate disrupts coordinate regulation of FXR-SHP-mediated cholesterol and bile acid homeostasis in mouse liver.

  2022cites this paper
• A Study to Evaluate Relative Bioavailability, Food Effect, and Pharmacodynamics of Tropifexor, a Farnesoid X Receptor Agonist, in Healthy Participants

  2022cites this paper
• Minocycline-induced disruption of the intestinal FXR/FGF15 axis impairs osteogenesis in mice

  2022influential citation
• A nonbile acid farnesoid X receptor agonist tropifexor potently inhibits cholestatic liver injury and fibrosis by modulating the gut–liver axis

  2021cites this paper
• University of Birmingham Steroid sulfation in adrenal tumors

  2021cites this paper
• Discovery of a tricyclic farnesoid X receptor agonist HEC96719, a clinical candidate for treatment of non-alcoholic steatohepatitis.

  2021cites this paper
• Review article: therapeutic aspects of bile acid signalling in the gut‐liver axis

  2021cites this paper
• Steroid sulfation in adrenal tumors.

  2021cites this paper
• Role of Farnesoid X Receptor in the Pathogenesis of Respiratory Diseases

  2020cites this paper
• Molecular Physiology of Bile Acid Signaling in Health, Disease and Aging.

  2020cites this paper
• Nuclear receptors in the kidney during health and disease.

  2020cites this paper
• Farnesoid X Receptor Activation Stimulates Organic Cations Transport in Human Renal Proximal Tubular Cells

  2020cites this paper
• Activation of farnesoid X receptor (FXR) induces crystallin zeta expression in mouse medullary collecting duct cells

  2020cites this paper
• Bile acid-based therapies for non-alcoholic steatohepatitis and alcoholic liver disease.

  2020influential citation
• Mechanism of Paeoniflorin in the Treatment of Bile Duct Ligation-Induced Cholestatic Liver Injury Using Integrated Metabolomics and Network Pharmacology

  2020cites this paper
• Changes in Enterohepatic Circulation after Duodenal–Jejunal Bypass and Reabsorption of Bile Acids in the Bilio-Pancreatic Limb

  2019cites this paper
• Bile acids and glucocorticoid metabolism in health and disease.

  2019cites this paper
• Intestinal Absorption of Bile Acids in Health and Disease.

  2019cites this paper
• Semisynthetic bile acids: a new therapeutic option for metabolic syndrome.

  2019cites this paper
• Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Non–Bile Acid FXR Agonist Tropifexor (LJN452) in Healthy Volunteers

  2019cites this paper
• Enhanced Microbial Bile Acid Deconjugation and Impaired Ileal Uptake in Pregnancy Repress Intestinal Regulation of Bile Acid Synthesis

  2019cites this paper
• Gluco-metabolic effects of pharmacotherapy-induced modulation of bile acid physiology.

  2019cites this paper
• The farnesoid X receptor agonist obeticholic acid upregulates biliary excretion of asymmetric dimethylarginine via MATE-1 during hepatic ischemia/reperfusion injury

  2018cites this paper
• The farnesoid X receptor: a potential target for expanding the therapeutic arsenal against kidney disease

  2018cites this paper
• Post-hepatectomy liver regeneration in the context of bile acid homeostasis and the gut-liver signaling axis

  2018cites this paper
• Farnesoid X Receptor Agonists Obeticholic Acid and Chenodeoxycholic Acid Increase Bile Acid Efflux in Sandwich-Cultured Human Hepatocytes: Functional Evidence and Mechanisms

  2018cites this paper
• Mechanisms Underlying Host-Microbiome Interactions in Pathophysiology of Human Diseases

  2018cites this paper
• Role of bile acids in inflammatory bowel disease

  2018cites this paper
• Farnesoid X receptor: A "homeostat" for hepatic nutrient metabolism.

  2018cites this paper
• Evaluation of varying dietary cholesterol levels on the gene regulatory actions and physiological effects of a grape seed procyanidin extract

  2018cites this paper
• Intestinal bile acid receptors are key regulators of glucose homeostasis

  2017cites this paper
• Western Diet Deregulates Bile Acid Homeostasis, Cell Proliferation, and Tumorigenesis in Colon.

  2017cites this paper
• Hepatocyte Nuclear Factor-1β Regulates Urinary Concentration and Response to Hypertonicity.

  2017cites this paper
• Bile Acid Receptor Farnesoid X Receptor: A Novel Therapeutic Target for Metabolic Diseases

  2017cites this paper
• Enterohepatic bile acid transporters and transcriptional control of their expression

  2017cites this paper
• Influence of Age and Frailty on Intestinal and Hepatic Bile Acid Transport in Male C57BL/6 Mice

  2017cites this paper
• Beneficial effects of bile acid receptor agonists in pulmonary disease models

  2017cites this paper
• Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway

  2017cites this paper
• FXR activation induces mitochondrial mediated apoptosis in breast cancer and synergizes with tamoxifen

  2016cites this paper
• Essential roles of bile acids and their nuclear receptors, FXR and PXR, in the cholestatic liver disease

  2016cites this paper
• Identification of functional farnesoid X receptors in brain neurons

  2016cites this paper
• Pharmacology of bile acid receptors: Evolution of bile acids from simple detergents to complex signaling molecules.

  2016cites this paper
• Role of farnesoid X receptor in cholestasis

  2016cites this paper
• Trimethylamine-N-oxide: a link between the gut microbiome, bile acid metabolism, and atherosclerosis

  2016cites this paper
• Mechanism of bile acid-regulated glucose and lipid metabolism in duodenal-jejunal bypass.

  2015cites this paper
• Bacterial metabolites directly modulate farnesoid X receptor activity

  2015cites this paper
• Bile Acids in Physiology, Pathology and Pharmacology.

  2015cites this paper
• Effects of cholestasis, bile acids and FXR on the adrenal glands

  2015cites this paper
• Bile acid nuclear receptor FXR and digestive system diseases

  2015cites this paper
• Clinical application of transcriptional activators of bile salt transporters☆

  2014cites this paper
• Bile Acid Signaling in Metabolic Disease and Drug Therapy

  2014cites this paper
• Role of farnesoid X receptor in inflammation and resolution

  2014cites this paper
• Genetic variations of bile salt transporters.

  2014cites this paper
• Homologue gene of bile acid transporters ntcp, asbt, and ost-alpha in rainbow trout Oncorhynchus mykiss: tissue expression, effect of fasting, and response to bile acid administration

  2014cites this paper
• Bile acid receptors as targets for drug development

  2014cites this paper
• Transcriptional Regulation of the Intestinal Nuclear Bile Acid Farnesoid X Receptor (FXR) by the caudal-related Homeobox 2 (CDX2)*

  2014cites this paper
• A novel RARα/CAR-mediated mechanism for regulation of human organic solute transporter-β gene expression.

  2014cites this paper
• STUDY OF FXR IN PRIMARY HUMAN HEPATOCYTES AND FXR REGULATED BA HOMEOSTASIS IN PARENTERAL NUTRITION ASSOCIATED LIVER DISEASES By Copyright 2014

  2014cites this paper
• Essential roles of bile acid receptors FXR and TGR5 as metabolic regulators

  2014cites this paper
• Farnesoid X receptor (FXR) gene deficiency impairs urine concentration in mice

  2014cites this paper
• Pleiotropic roles of bile acids in metabolism.

  2013cites this paper
• Differential activation of the human farnesoid X receptor depends on the pattern of expressed isoforms and the bile acid pool composition.

  2013cites this paper
• FXR signaling in the enterohepatic system.

  2013cites this paper
• Repression of Farnesoid X Receptor Contributes to Biliary Injuries of Liver Grafts Through Disturbing Cholangiocyte Bile Acid Transport

  2013cites this paper
• Identification of Functionally Relevant Lysine Residues That Modulate Human Farnesoid X Receptor Activation

  2013influential citation
• The heteromeric organic solute transporter, OSTα-OSTβ/SLC51: a transporter for steroid-derived molecules.

  2013cites this paper
• Identification of functional relevant lysine residues that modulate human farnesoid x receptor (hFXR) activation Molecular Pharmacology Fast Forward.

  2013cites this paper
• The role of glucocorticoid metabolism in bile acid homeostasis

  2013cites this paper
• Thermodynamic and solution state NMR characterization of the binding of secondary and conjugated bile acids to STARD5.

  2013cites this paper
• From NAFLD to NASH and HCC: pathogenetic mechanisms and therapeutic insights.

  2013cites this paper
• Bile Acid-Mediated Control of Liver Triglycerides

  2013cites this paper
• Nuclear receptors in bile acid metabolism

  2013influential citation
• STARD5 specific ligand binding: comparison with STARD1 and STARD4 subfamilies.

  2013cites this paper
• Understanding the role of the intestine in the molecular hypotriglyceridemic actions of a grape seed procyanidin extract

  2013cites this paper
• Comparative effects of 1α‐hydroxyvitamin D3 and 1,25‐dihydroxyvitamin D3 on transporters and enzymes in fxr(+/+) and fxr(‐/‐) mice

  2013cites this paper
• Association of genetic variation in the NR1H4 gene, encoding the nuclear bile acid receptor FXR, with inflammatory bowel disease

  2012cites this paper
• Nuclear receptor control of enterohepatic circulation.

  2012cites this paper
• Unusual binding of ursodeoxycholic acid to ileal bile acid binding protein: role in activation of FXRα[S]

  2012cites this paper